New hope for AML patients: experimental drug combo tested
Disease control
Completed
This study tested a new drug called liposomal annamycin combined with standard chemotherapy (cytarabine) in 22 adults with acute myeloid leukemia (AML). The goal was to find the safest dose and see if the combination can control the disease. Participants had either newly diagnose…
Phase: PHASE1, PHASE2 • Sponsor: Moleculin Biotech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC